FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014978327> ?p ?o ?g. }

• W2014978327 endingPage "300" @default.
• W2014978327 startingPage "295" @default.
• W2014978327 abstract "To compare rates of cognitive decline between probable Alzheimer's disease (AD) patients treated with long-duration cholinesterase inhibitors (ChE-Is) and those who remained untreated.ChE-Is, including donepezil and tracrine, have shown beneficial effects on cognition and global functioning in patients with AD. The duration of these benefits is unknown because the longest double-blind placebo-controlled studies reported were only approximately 6 months long. Ethical concerns regarding randomization of patients to placebo for long periods make it difficult to undertake trials of longer duration.We identified patients in 4 AD centers who were or were not consistently treated with ChE-Is and who had demographic, psychometric and follow-up data. We compared 205 ChE-I-treated and 218 untreated AD patients on baseline variables hypothesized to differ between these groups, on baseline Mini Mental Status Examination (MMSE) scores and on rates of MMSE change at 1 year. The analysis was performed initially with all ChE-I-treated patients as a single group versus untreated subjects, and then with donepezil versus untreated subjects and tacrine versus untreated subjects.As expected, treated and untreated patients differed with respect to age, education, ethnicity, percentage of community dwelling and exact days of follow-up (ANOVA and chi2) in several comparisons, but did not differ on baseline MMSE score. These baseline variables were highly intercorrelated. MMSE scores declined significantly more slowly after 1 year of ChE-I treatment compared to untreated patients (p = 0.05) after controlling for baseline differences in age, education, ethnicity and percentage of community dwelling. Slowing of decline was significant in the donepezil-treated patients (p = 0.007) but not in the tacrine-treated group (p = 0.33).This study, utilizing concurrent, nonrandomized controls, suggests that donepezil continues to have efficacy over at least the first year of therapy. Other studies are needed to determine whether the benefits are maintained beyond 1 year." @default.
• W2014978327 created "2016-06-24" @default.
• W2014978327 creator A5013387689 @default.
• W2014978327 creator A5019373426 @default.
• W2014978327 creator A5022814721 @default.
• W2014978327 creator A5037327989 @default.
• W2014978327 creator A5052952294 @default.
• W2014978327 creator A5058250192 @default.
• W2014978327 creator A5059103675 @default.
• W2014978327 creator A5068308578 @default.
• W2014978327 creator A5071364728 @default.
• W2014978327 date "2001-01-01" @default.
• W2014978327 modified "2023-09-26" @default.
• W2014978327 title "Chronic Donepezil Treatment Is Associated with Slowed Cognitive Decline in Alzheimer’s Disease" @default.
• W2014978327 cites W2055727638 @default.
• W2014978327 cites W2065001283 @default.
• W2014978327 cites W2326200998 @default.
• W2014978327 cites W4232629811 @default.
• W2014978327 cites W4233035841 @default.
• W2014978327 cites W4250196567 @default.
• W2014978327 doi "https://doi.org/10.1159/000051272" @default.
• W2014978327 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11351141" @default.
• W2014978327 hasPublicationYear "2001" @default.
• W2014978327 type Work @default.
• W2014978327 sameAs 2014978327 @default.
• W2014978327 citedByCount "107" @default.
• W2014978327 countsByYear W20149783272013 @default.
• W2014978327 countsByYear W20149783272014 @default.
• W2014978327 countsByYear W20149783272015 @default.
• W2014978327 countsByYear W20149783272016 @default.
• W2014978327 countsByYear W20149783272017 @default.
• W2014978327 countsByYear W20149783272018 @default.
• W2014978327 countsByYear W20149783272019 @default.
• W2014978327 countsByYear W20149783272020 @default.
• W2014978327 countsByYear W20149783272021 @default.
• W2014978327 countsByYear W20149783272022 @default.
• W2014978327 countsByYear W20149783272023 @default.
• W2014978327 crossrefType "journal-article" @default.
• W2014978327 hasAuthorship W2014978327A5013387689 @default.
• W2014978327 hasAuthorship W2014978327A5019373426 @default.
• W2014978327 hasAuthorship W2014978327A5022814721 @default.
• W2014978327 hasAuthorship W2014978327A5037327989 @default.
• W2014978327 hasAuthorship W2014978327A5052952294 @default.
• W2014978327 hasAuthorship W2014978327A5058250192 @default.
• W2014978327 hasAuthorship W2014978327A5059103675 @default.
• W2014978327 hasAuthorship W2014978327A5068308578 @default.
• W2014978327 hasAuthorship W2014978327A5071364728 @default.
• W2014978327 hasConcept C126322002 @default.
• W2014978327 hasConcept C142724271 @default.
• W2014978327 hasConcept C15744967 @default.
• W2014978327 hasConcept C181199279 @default.
• W2014978327 hasConcept C185592680 @default.
• W2014978327 hasConcept C204243189 @default.
• W2014978327 hasConcept C204787440 @default.
• W2014978327 hasConcept C27081682 @default.
• W2014978327 hasConcept C2776332859 @default.
• W2014978327 hasConcept C2778816929 @default.
• W2014978327 hasConcept C2779046751 @default.
• W2014978327 hasConcept C2779134260 @default.
• W2014978327 hasConcept C2779483572 @default.
• W2014978327 hasConcept C2780904820 @default.
• W2014978327 hasConcept C2984863031 @default.
• W2014978327 hasConcept C31896038 @default.
• W2014978327 hasConcept C502032728 @default.
• W2014978327 hasConcept C535046627 @default.
• W2014978327 hasConcept C55493867 @default.
• W2014978327 hasConcept C71924100 @default.
• W2014978327 hasConceptScore W2014978327C126322002 @default.
• W2014978327 hasConceptScore W2014978327C142724271 @default.
• W2014978327 hasConceptScore W2014978327C15744967 @default.
• W2014978327 hasConceptScore W2014978327C181199279 @default.
• W2014978327 hasConceptScore W2014978327C185592680 @default.
• W2014978327 hasConceptScore W2014978327C204243189 @default.
• W2014978327 hasConceptScore W2014978327C204787440 @default.
• W2014978327 hasConceptScore W2014978327C27081682 @default.
• W2014978327 hasConceptScore W2014978327C2776332859 @default.
• W2014978327 hasConceptScore W2014978327C2778816929 @default.
• W2014978327 hasConceptScore W2014978327C2779046751 @default.
• W2014978327 hasConceptScore W2014978327C2779134260 @default.
• W2014978327 hasConceptScore W2014978327C2779483572 @default.
• W2014978327 hasConceptScore W2014978327C2780904820 @default.
• W2014978327 hasConceptScore W2014978327C2984863031 @default.
• W2014978327 hasConceptScore W2014978327C31896038 @default.
• W2014978327 hasConceptScore W2014978327C502032728 @default.
• W2014978327 hasConceptScore W2014978327C535046627 @default.
• W2014978327 hasConceptScore W2014978327C55493867 @default.
• W2014978327 hasConceptScore W2014978327C71924100 @default.
• W2014978327 hasIssue "4" @default.
• W2014978327 hasLocation W20149783271 @default.
• W2014978327 hasLocation W20149783272 @default.
• W2014978327 hasOpenAccess W2014978327 @default.
• W2014978327 hasPrimaryLocation W20149783271 @default.
• W2014978327 hasRelatedWork W167815567 @default.
• W2014978327 hasRelatedWork W1996956475 @default.
• W2014978327 hasRelatedWork W2014978327 @default.
• W2014978327 hasRelatedWork W2022344152 @default.
• W2014978327 hasRelatedWork W2037986700 @default.
• W2014978327 hasRelatedWork W2086916510 @default.

• next